Janux Therapeutics, Inc. (JANX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Janux Therapeutics, Inc. (JANX)
Company Performance

Current Price

as of Oct 16, 2024

$49.41

P/E Ratio

N/A

Market Cap

$2.58B

Description

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.

Metrics

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerJANX
  • Price$49.41-6.31%

Trading Information

  • Market Cap$2.58B
  • Float74.65%
  • Average Daily Volume (1m)645,017
  • Average Daily Volume (3m)564,102
  • EPS-$0.92

Company

  • Revenue$15.13M
  • Rev Growth (1yr)741.72%
  • Net Income-$5.96M
  • Gross Margin94.31%
  • EBITDA Margin-149.67%
  • EBITDA-$13.32M
  • EV$1.66B
  • EV/Revenue109.64
  • P/EN/A
  • P/S177.86
  • P/B3.92
Documents